Save time and jump to the most important pieces.
LatAm Logistic Properties is one of the only Institutional Industrial Platforms operating across the region, bringing the development of class A warehouses to undersupplied marketsEstimated post-transaction enterprise value of $578 Million based on a minimum of $25 Million in net cash proceeds to fund growth (assuming 70% redemptions from two's trust account)LatAm Logistic Properties' management will roll 100% of their existing shares into equity of the combined company ZEPHYR COVE, Nev. and SAN JOSÉ, Costa Rica, Aug. 15, 2023 (GLOBE NEWSWIRE) -- two (NYSE:TWOA) ("TWOA"), a special purpose acquisition company, and LatAm Logistic Properties S.A. (d/b/a LatAm Logistic Properties) ("LLP"), a
Projected Rental Revenue Exceeds $43 Million Over Lease Term, Highest Value Contract to Date SAN JOSÉ, Costa Rica, March 18, 2024 /PRNewswire/ -- LatAm Logistic Properties, S.A. (d/b/a LatAm Logistic Properties) ("LLP"), a leading developer, owner and manager of institutional quality, Class A industrial and logistics real estate in Central and South America, has signed a lease agreement in Peru with a leading, globally-renowned food and beverage company. The agreement is considered a milestone as it represents LLP's highest value contract to date, with projected rental revenue of over $43 million during the lease term. The ten-year lease for 239,000 square feet, representing approximately 6
ZEPHYR COVE, Nev. and SAN JOSÉ, Costa Rica, March 15, 2024 (GLOBE NEWSWIRE) -- two (NYSE:TWOA) ("TWOA"), a special purpose acquisition company, and LatAm Logistic Properties, S.A. (d/b/a LatAm Logistic Properties) ("LLP"), a leading developer, owner, and manager of institutional quality, Class A industrial and logistics real estate in Central and South America, will host a virtual investor day on Tuesday, March 19, 2024, beginning at 2:00 p.m. ET. The virtual investor day will include presentations from LLP's leadership team. The presentations will provide LLP's latest views on market opportunities, sources of competitive differentiation, core business drivers and financial outlook. There
ZEPHYR COVE, Nev. and SAN JOSÉ, Costa Rica, March 13, 2024 (GLOBE NEWSWIRE) -- two (NYSE:TWOA) ("TWOA"), a special purpose acquisition company, and LatAm Logistic Properties, S.A. (d/b/a LatAm Logistic Properties) ("LLP"), a leading developer, owner, and manager of institutional quality, Class A industrial and logistics real estate in Central and South America, today announced that the Securities and Exchange Commission ("SEC") has declared effective the amended registration statement on Form F-4 (the "Registration Statement") filed by Logistic Properties of the Americas ("Pubco") in connection with LLP and TWOA's previously announced proposed business combination (the "Business Combinatio
For Immediate Release: May 04, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA Center for Drug Evaluation and Research (CDER) continually monitors our ability to meet user fee commitments. To maintain transparency during the COVID-19 public health emergency, CDER posts periodic updates to the CDER’s Work to
For Immediate Release: April 30, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On April 28, the FDA approved an abbreviated new drug application (ANDA) for 23.4% Sodium Chloride Injection USP, 120 mEq/30 mL (4 mEq/mL) single dose vial, indicated as an additive in parenteral (injection) fluid therapy for use in pat
For Immediate Release: April 30, 2021 Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. “Chronic kidney disease is an important public health issue, and there is a signif
SC 13G - two (0001843988) (Subject)
SC 13G/A - two (0001843988) (Subject)
SC 13G/A - two (0001843988) (Subject)
15-12G - two (0001843988) (Filer)
25-NSE - two (0001843988) (Subject)
425 - two (0001843988) (Subject)
4 - two (0001843988) (Issuer)
4 - two (0001843988) (Issuer)
4 - two (0001843988) (Issuer)